China Endothelin Receptor Antagonist Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Endothelin Receptor Antagonist industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • United Therapeutics Corporation

    • Merck & Co Inc

    • SteadyMed Ltd

    • Arena Pharmaceuticals Inc

    • Actelion Pharmaceuticals Ltd

    • GlaxoSmithKline plc

    • Reata Pharmaceuticals Inc

    • Bayer AG

    • Pfizer Inc

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Clinic

    • Health care

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Endothelin Receptor Antagonist Market Overview 2018-2029

    • 1.1 China Endothelin Receptor Antagonist Industry Development Overview

    • 1.2 China Endothelin Receptor Antagonist Industry Development History

    • 1.3 China Endothelin Receptor Antagonist Industry Market Size (2018-2029)

    • 1.4 China Endothelin Receptor Antagonist Market Analysis by Type from Production Side

      • 1.4.1 China Endothelin Receptor Antagonist Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Endothelin Receptor Antagonist Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Endothelin Receptor Antagonist Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Endothelin Receptor Antagonist Market Analysis by Application from Consumption End

      • 1.5.1 China Endothelin Receptor Antagonist Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Endothelin Receptor Antagonist Sales Volume, Sales Value and Growth Rate of Health care (2018-2029)

      • 1.5.3 China Endothelin Receptor Antagonist Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Endothelin Receptor Antagonist Market Analysis by Region

      • 1.6.1 North China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    Chapter 2 China Endothelin Receptor Antagonist Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Endothelin Receptor Antagonist Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Endothelin Receptor Antagonist Market Status and Competition Analysis in 2023

      • 2.2.3 China Endothelin Receptor Antagonist Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Endothelin Receptor Antagonist Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Endothelin Receptor Antagonist Industry Development

    Chapter 3 Endothelin Receptor AntagonistIndustry Chain Analysis

    • 3.1 Endothelin Receptor Antagonist Industry Chain

    • 3.2 Endothelin Receptor Antagonist Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Endothelin Receptor Antagonist Market

    • 3.3 Endothelin Receptor Antagonist Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Endothelin Receptor Antagonist Market

    Chapter 4 China Endothelin Receptor Antagonist Market, by Type

    • 4.1 China Endothelin Receptor Antagonist Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Endothelin Receptor Antagonist Total Production Volume and Growth Rate from Production Side

    • 4.5 China Endothelin Receptor Antagonist Production Volume and Growth Rate, by Type

      • 4.5.1 China Endothelin Receptor Antagonist Production Volume and Growth Rate of Type 1

      • 4.5.2 China Endothelin Receptor Antagonist Production Volume and Growth Rate of Type 2

      • 4.5.3 China Endothelin Receptor Antagonist Production Volume and Growth Rate of Type 3

    Chapter 5 China Endothelin Receptor Antagonist Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Endothelin Receptor Antagonist Total Market Size and Growth Rate from Consumption End

    • 5.5 China Endothelin Receptor Antagonist Market Size and Growth Rate, by Application

      • 5.5.1 China Endothelin Receptor Antagonist Market Size and Growth Rate of Clinic

      • 5.5.2 China Endothelin Receptor Antagonist Market Size and Growth Rate of Health care

      • 5.5.3 China Endothelin Receptor Antagonist Market Size and Growth Rate of Hospital

    Chapter 6 China Endothelin Receptor Antagonist Market, by Region

    • 6.1 China Endothelin Receptor Antagonist Production Volume and Production Value, by Region

    • 6.2 China Endothelin Receptor Antagonist Sales Volume and Sales Value, by Region

    Chapter 7 North China Endothelin Receptor Antagonist Market Analysis

    • 7.1 North China Endothelin Receptor Antagonist Market, by Type

    • 7.2 North China Endothelin Receptor Antagonist Market, by Application

    Chapter 8 Central China Endothelin Receptor Antagonist Market Analysis

    • 8.1 Central China Endothelin Receptor Antagonist Market, by Type

    • 8.2 Central China Endothelin Receptor Antagonist Market, by Application

    Chapter 9 South China Endothelin Receptor Antagonist Market Analysis

    • 9.1 South China Endothelin Receptor Antagonist Market, by Type

    • 9.2 South China Endothelin Receptor Antagonist Market, by Application

    Chapter 10 East China Endothelin Receptor Antagonist Market Analysis

    • 10.1 East China Endothelin Receptor Antagonist Market, by Type

    • 10.2 East China Endothelin Receptor Antagonist Market, by Application

    Chapter 11 Northeast China Endothelin Receptor Antagonist Market Analysis

    • 11.1 Northeast China Endothelin Receptor Antagonist Market, by Type

    • 11.2 Northeast China Endothelin Receptor Antagonist Market, by Application

    Chapter 12 Southwest China Endothelin Receptor Antagonist Market Analysis

    • 12.1 Southwest China Endothelin Receptor Antagonist Market, by Type

    • 12.2 Southwest China Endothelin Receptor Antagonist Market, by Application

    Chapter 13 Northwest China Endothelin Receptor Antagonist Market Analysis

    • 13.1 Northwest China Endothelin Receptor Antagonist Market, by Type

    • 13.2 Northwest China Endothelin Receptor Antagonist Market, by Application

    Chapter 14 Company Profiles

      • 14.1 United Therapeutics Corporation

        • 14.1.1 United Therapeutics Corporation Company Profile

        • 14.1.2 United Therapeutics Corporation Endothelin Receptor Antagonist Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Merck & Co Inc

        • 14.2.1 Merck & Co Inc Company Profile

        • 14.2.2 Merck & Co Inc Endothelin Receptor Antagonist Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 SteadyMed Ltd

        • 14.3.1 SteadyMed Ltd Company Profile

        • 14.3.2 SteadyMed Ltd Endothelin Receptor Antagonist Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Arena Pharmaceuticals Inc

        • 14.4.1 Arena Pharmaceuticals Inc Company Profile

        • 14.4.2 Arena Pharmaceuticals Inc Endothelin Receptor Antagonist Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Actelion Pharmaceuticals Ltd

        • 14.5.1 Actelion Pharmaceuticals Ltd Company Profile

        • 14.5.2 Actelion Pharmaceuticals Ltd Endothelin Receptor Antagonist Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GlaxoSmithKline plc

        • 14.6.1 GlaxoSmithKline plc Company Profile

        • 14.6.2 GlaxoSmithKline plc Endothelin Receptor Antagonist Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Reata Pharmaceuticals Inc

        • 14.7.1 Reata Pharmaceuticals Inc Company Profile

        • 14.7.2 Reata Pharmaceuticals Inc Endothelin Receptor Antagonist Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bayer AG

        • 14.8.1 Bayer AG Company Profile

        • 14.8.2 Bayer AG Endothelin Receptor Antagonist Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Pfizer Inc

        • 14.9.1 Pfizer Inc Company Profile

        • 14.9.2 Pfizer Inc Endothelin Receptor Antagonist Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Endothelin Receptor Antagonist Industry Research Conclusions

    • 15.2 Endothelin Receptor Antagonist Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Endothelin Receptor Antagonist Industry Market Size (2018-2029)

    • Figure China Endothelin Receptor Antagonist Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Endothelin Receptor Antagonist Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Endothelin Receptor Antagonist Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Endothelin Receptor Antagonist Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Endothelin Receptor Antagonist Sales Volume, Sales Value and Growth Rate of Health care (2018-2029)

    • Figure China Endothelin Receptor Antagonist Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    • Figure Central China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    • Figure South China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    • Figure East China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Endothelin Receptor Antagonist Market Size and Growth Rate from 2018-2029

    • Figure Endothelin Receptor Antagonist Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Endothelin Receptor Antagonist Market Share by Type in 2018

    • Figure China Endothelin Receptor Antagonist Market Share by Type in 2023

    • Figure China Endothelin Receptor Antagonist Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Endothelin Receptor Antagonist Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Endothelin Receptor Antagonist Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Endothelin Receptor Antagonist Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Endothelin Receptor Antagonist Market Share by Application in 2018

    • Figure China Endothelin Receptor Antagonist Market Share by Application in 2023

    • Figure China Endothelin Receptor Antagonist Total Market Size and Growth Rate from Consumption End

    • Figure China Endothelin Receptor Antagonist Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Endothelin Receptor Antagonist Market Size and Growth Rate of Health care (2018-2023)

    • Figure China Endothelin Receptor Antagonist Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Endothelin Receptor Antagonist Production Volume by Region (2018-2023)

    • Table China Endothelin Receptor Antagonist Production Volume Share by Region (2018-2023)

    • Figure China Endothelin Receptor Antagonist Production Volume Share by Region (2018-2023)

    • Table China Endothelin Receptor Antagonist Production Value by Region (2018-2023)

    • Table China Endothelin Receptor Antagonist Production Value Share by Region (2018-2023)

    • Figure China Endothelin Receptor Antagonist Production Value Share by Region (2018-2023)

    • Table China Endothelin Receptor Antagonist Sales Volume by Region (2018-2023)

    • Table China Endothelin Receptor Antagonist Sales Volume Share by Region (2018-2023)

    • Figure China Endothelin Receptor Antagonist Sales Volume Share by Region (2018-2023)

    • Table China Endothelin Receptor Antagonist Sales Value by Region (2018-2023)

    • Table China Endothelin Receptor Antagonist Sales Value Share by Region (2018-2023)

    • Figure China Endothelin Receptor Antagonist Sales Value Share by Region (2018-2023)

    • Table North China Endothelin Receptor Antagonist Production Volume by Type (2018-2023)

    • Table North China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Figure North China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Table North China Endothelin Receptor Antagonist Sales Volume by Application (2018-2023)

    • Table North China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Figure North China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Table Central China Endothelin Receptor Antagonist Production Volume by Type (2018-2023)

    • Table Central China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Figure Central China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Table Central China Endothelin Receptor Antagonist Sales Volume by Application (2018-2023)

    • Table Central China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Figure Central China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Table South China Endothelin Receptor Antagonist Production Volume by Type (2018-2023)

    • Table South China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Figure South China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Table South China Endothelin Receptor Antagonist Sales Volume by Application (2018-2023)

    • Table South China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Figure South China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Table East China Endothelin Receptor Antagonist Production Volume by Type (2018-2023)

    • Table East China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Figure East China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Table East China Endothelin Receptor Antagonist Sales Volume by Application (2018-2023)

    • Table East China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Figure East China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Table Northeast China Endothelin Receptor Antagonist Production Volume by Type (2018-2023)

    • Table Northeast China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Figure Northeast China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Table Northeast China Endothelin Receptor Antagonist Sales Volume by Application (2018-2023)

    • Table Northeast China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Table Southwest China Endothelin Receptor Antagonist Production Volume by Type (2018-2023)

    • Table Southwest China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Figure Southwest China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Table Southwest China Endothelin Receptor Antagonist Sales Volume by Application (2018-2023)

    • Table Southwest China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Table Northwest China Endothelin Receptor Antagonist Production Volume by Type (2018-2023)

    • Table Northwest China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Figure Northwest China Endothelin Receptor Antagonist Production Volume Share by Type (2018-2023)

    • Table Northwest China Endothelin Receptor Antagonist Sales Volume by Application (2018-2023)

    • Table Northwest China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Endothelin Receptor Antagonist Sales Volume Share by Application (2018-2023)

    • Table United Therapeutics Corporation Company Profile

    • Table United Therapeutics Corporation Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Inc Company Profile

    • Table Merck & Co Inc Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table SteadyMed Ltd Company Profile

    • Table SteadyMed Ltd Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table Arena Pharmaceuticals Inc Company Profile

    • Table Arena Pharmaceuticals Inc Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table Actelion Pharmaceuticals Ltd Company Profile

    • Table Actelion Pharmaceuticals Ltd Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table Reata Pharmaceuticals Inc Company Profile

    • Table Reata Pharmaceuticals Inc Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Endothelin Receptor Antagonist Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.